ZBHNYQHealthcare·Medical Devices#10 in industry

Zimmer Biomet Holdings, Inc.

Reports tomorrow· 2026-04-28

+7.7% · 90d

$92.59

+1.33 (+1.46%)

After-Hours $92.59(+0.00)

News

(2)

April 2026

Apr 1, 20263 weeks agoDEF 14AHealthcare

ZIMMER BIOMET HOLDINGS, INC. — DEF 14A Filing

ZBHZIMMER BIOMET HOLDINGS, INC.

# 🧾 What This Document Is This is Zimmer Biomet’s **DEF 14A proxy statement**, filed ahead of its 2026 annual shareholder meeting. It explains what shareholders will vote on, provides details about the board and executive pay, and includes a shareholder proposal. 👉 Think of it as a “voter guid

Read summaryView on SEC EDGAR

Apr 1, 20263 weeks agoARSHealthcare

ZIMMER BIOMET HOLDINGS, INC. — ARS Filing

ZBHZIMMER BIOMET HOLDINGS, INC.

# 🧾 What This Document Is This is Zimmer Biomet's **Annual Report to Shareholders** for the fiscal year 2023. Think of it as the company's annual "report card" and strategic plan rolled into one, sent directly to its owners (the shareholders). It provides a comprehensive look at their performance,

Read summaryView on SEC EDGAR

Key Data

Market Cap$17.92B

Open$91.28

Prev Close$91.26

Day Range$91.28 – $93.78

52W Range$84.59 – $108.29

Volume2,117,361

P/E (TTM)26.08

EPS$3.55

Dividend Yield1.05%

Beta0.61

Profit Margin8.57%

Revenue Growth10.90%

Price Target$102.95(+11.2%)

Next Earnings2026-04-28(1d)

Analyst Ratings

Buy27 analysts

Buy 8Hold 17Sell 2

About

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Healthcare · Medical Devices

17,000 employees

www.zimmerbiomet.com